Boston 25 News goes ‘Inside Moderna’: How a small local company became a household name
Cambridge-based Moderna surged to the front of the vaccine race, but company leaders say it did not happen overnight.
Boston 25 News goes ‘Inside Moderna’: From side effects to skepticism to safety
Boston 25 News anchor Vanessa Welch spent weeks interviewing Moderna leaders, from the president to the scientists who helped make the COVID-19 mRNA breakthrough, to get answers in a series of reports.
Boston 25′s Vanessa Welch sits down with Moderna president Stephen Hoge
Hours after Moderna announced its vaccine was 96% effective in 12 to 17-year-olds – Boston 25 News anchor Vanessa Welch sat down with Moderna president Stephen Hoge at their Cambridge headquarters.
/cloudfront-us-east-1.images.arcpublishing.com/cmg/7QOJU3BNCJERBNKJC5LWTBYFLU.png)
